BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 32043519)

  • 1. Bioinformatics analysis of prognostic significance of COL10A1 in breast cancer.
    Zhang M; Chen H; Wang M; Bai F; Wu K
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32043519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of prognostic significance of BIRC5 in breast cancer using integrative bioinformatics analysis.
    Dai JB; Zhu B; Lin WJ; Gao HY; Dai H; Zheng L; Shi WH; Chen WX
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32043523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatics analysis revealing prognostic significance of
    Chen WX; Yang LG; Xu LY; Cheng L; Qian Q; Sun L; Zhu YL
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30898978
    [No Abstract]   [Full Text] [Related]  

  • 4. Bioinformatics analysis of prognostic value of
    Chen WX; Cheng L; Xu LY; Qian Q; Zhu YL
    Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30837324
    [No Abstract]   [Full Text] [Related]  

  • 5. Cell division cycle proteinising prognostic biomarker of breast cancer.
    Cheng L; Huang YZ; Chen WX; Shi L; Li Z; Zhang X; Dai XY; Wei JF; Ding Q
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32285914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatics analysis of prognostic value of PITX1 gene in breast cancer.
    Wang Q; Zhao S; Gan L; Zhuang Z
    Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32830857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of Collagen type X alpha 1 (COL10A1) expression and prognostic significance in gastric cancer based on bioinformatics.
    Chen S; Wei Y; Liu H; Gong Y; Zhou Y; Yang H; Tang L
    Bioengineered; 2021 Dec; 12(1):127-137. PubMed ID: 33371777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mining Prognostic Significance of MEG3 in Human Breast Cancer Using Bioinformatics Analysis.
    Cui X; Yi Q; Jing X; Huang Y; Tian J; Long C; Xiang Z; Liu J; Zhang C; Tan B; Li Y; Zhu J
    Cell Physiol Biochem; 2018; 50(1):41-51. PubMed ID: 30278461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression Pattern and Prognostic Value of EPHA/EFNA in Breast Cancer by Bioinformatics Analysis: Revealing Its Importance in Chemotherapy.
    Liang Z; Wang X; Dong K; Li X; Qin C; Zhou H
    Biomed Res Int; 2021; 2021():5575704. PubMed ID: 33977106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatic analysis of the expression and prognostic value of chromobox family proteins in human breast cancer.
    Li X; Gou J; Li H; Yang X
    Sci Rep; 2020 Oct; 10(1):17739. PubMed ID: 33082469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD24 is a Potential Biomarker for Prognosis in Human Breast Carcinoma.
    Jing X; Cui X; Liang H; Hao C; Yang Z; Li X; Yang X; Han C
    Cell Physiol Biochem; 2018; 48(1):111-119. PubMed ID: 30001552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatics analysis of potential prognostic biomarkers among Krüppel-like transcription Factors (KLFs) in breast cancer.
    Cheng L; Shi L; Dai H
    Cancer Biomark; 2019; 26(4):411-420. PubMed ID: 31640084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatics analysis revealing prognostic significance of TIMP2 gene in breast cancer.
    Chen WQ; Yang SJ; Xu WX; Deng F; Wang DD; Tang JH
    Medicine (Baltimore); 2021 Oct; 100(42):e27489. PubMed ID: 34678879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of MUC1 predicts poor prognosis in patients with breast cancer.
    Jing X; Liang H; Hao C; Yang X; Cui X
    Oncol Rep; 2019 Feb; 41(2):801-810. PubMed ID: 30483806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression and clinical significance of secretory leukocyte proteinase inhibitor (SLPI) in mammary carcinoma using bioinformatics analysis.
    Xie W; Zhang H; Qin S; Zhang J; Fan X; Yin Y; Liang R; Long H; Yi W; Fu D; Ma C; Lv M; Yu F
    Gene; 2019 Dec; 720():144088. PubMed ID: 31476404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Keratin 17 is overexpressed and predicts poor survival in estrogen receptor-negative/human epidermal growth factor receptor-2-negative breast cancer.
    Merkin RD; Vanner EA; Romeiser JL; Shroyer ALW; Escobar-Hoyos LF; Li J; Powers RS; Burke S; Shroyer KR
    Hum Pathol; 2017 Apr; 62():23-32. PubMed ID: 27816721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PPFIA1 is upregulated in liver metastasis of breast cancer and is a potential poor prognostic indicator of metastatic relapse.
    Yang J; Wu NN; Huang DJ; Luo YC; Huang JZ; He HY; Lu HL; Song WL
    Tumour Biol; 2017 Jul; 39(7):1010428317713492. PubMed ID: 28720060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of differentially expressed genes between triple and non-triple-negative breast cancer using bioinformatics analysis.
    Zhai Q; Li H; Sun L; Yuan Y; Wang X
    Breast Cancer; 2019 Nov; 26(6):784-791. PubMed ID: 31197620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age related influence of triple receptor status on metastatic breast cancer post relapse survival.
    Todorovic-Rakovic N; Neskovic-Konstantinovic Z
    J BUON; 2013; 18(4):851-8. PubMed ID: 24344008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatics identification of CCL8/21 as potential prognostic biomarkers in breast cancer microenvironment.
    Chen B; Zhang S; Li Q; Wu S; He H; Huang J
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33146700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.